Invitrogen Corporation and Cytovance Biologics Collaborate to Develop New Bioreactor Manufacturing Process of Invitrogen's New CD OptiCHO(TM) Media Platform

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance® Biologics LLC, a biopharmaceutical contract manufacturing company specializing in mammalian cell culture, today announced the completion of a collaboration with Invitrogen’s PD-Direct® Bioprocess Services. Cytovance Biologics has successfully completed the process transfer and scale-up to 100 L of a fed-batch bioreactor production process using Invitrogen’s new CD OptiCHO™ Medium and CHO CD EfficientFeed™ supplement designed specifically for the fed-batch production process.